The Champions Advantage

Dec 20 2011 1:25 PM

Champions Oncology was founded by world leaders in the field of cancer diagnosis, treatment, and research. The team you will work with is comprised of professionals who have experience in drug development, preclinical studies and identification of emerging biomarkers for personalized treatment approaches.

Champions Personalized Oncology Solutions

  • Champions Personalized TumorGrafts empower patients and physicians with a new preclinical model that has shown to be predictive of a patient’s clinical response to anticancer therapies.
  • Champions works with leading experts in gene sequencing and helps  analyze  the mutational profile of your patient’s  tumor to help guide your treatment process.

.

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.